Psoriatic arthritis is an inflammatory autoimmune disease that affects both the skin and joints. Reviewed by a board-certified rheumatologist.
Psoriatic arthritisCOVID-19 has changed the global health system and has great impact on different types of medical specialties including, dermatology and rheumatology. This point is important because although these two specialties are distinct subfields of medicine, there is some overlap between them....
Patients With Arthritis, IBD, Experience High Rates of Long Covid Affecting QoL ByVictoria Johnson September 17th 2024 Notably, people with fewer vaccine doses were more likely to experience post-acute sequelae of COVID-19. Higher Risk of Interstitial Lung Disease in Patients With RA, PsA Initia...
Patients With Arthritis, IBD, Experience High Rates of Long Covid Affecting QoL ByVictoria Johnson September 17th 2024 Notably, people with fewer vaccine doses were more likely to experience post-acute sequelae of COVID-19. Higher Risk of Interstitial Lung Disease in Patients With RA, PsA Initia...
Introduction: Psoriasis (PsO) is associated with the development of psoriatic arthritis (PsA). Patients with PsO often experience pre-PsA musculoskeletal (... JF Merola,D Patil,A Egana,... - 《Dermatology & Therapy》 被引量: 0发表: 2023年 COVID-19 Vaccine Effectiveness among Patients with ...
Previously, upadacitinib improved symptoms through 2 years in the SELECT-PsA 1 trial for those with psoriatic arthritis with prior inadequate response or intolerance to ≥1 non-biologic disease-modifying antirheumatic drug. The efficacy of upadacitinib was maintained for 3 years in patie...
In this Q&A, Fabian Proft, MD, discussed the findings of his study that evaluated the DAPSA using a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis. In patients withpsoriatic arthritis (PsA), a quick quantitative C-reactive ...
Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic arthritis. The updated Prescri...
psoriatic arthritis f1are up after a second dose of bnt162b2 covid 19 mma vac cine19 vaccination. With the widespread availability of the COVID-19 vaccine, dermatologists need to be prepared to discuss the risks and benefits of vaccination, keeping in mind that vaccines against SARS-CoV-2 ...
COVID-19GRAPPApsoriasispsoriaticvaccinesGiven the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD), a session was devoted at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting to d...